These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17696918)

  • 1. Dermatopathological indicators of poor melanoma prognosis are significantly inversely correlated with the expression of NM23 protein in primary cutaneous melanoma.
    Ferrari D; Lombardi M; Ricci R; Michiara M; Santini M; De Panfilis G
    J Cutan Pathol; 2007 Sep; 34(9):705-12. PubMed ID: 17696918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nm23 in melanoma progression and its prognostic significance.
    Betke H; Korabiowska M; Brinck U; Trybus-Gałuszka H; Kellner S; Okoń K; Stachura J; Droese M
    Pol J Pathol; 1998; 49(2):93-6. PubMed ID: 9798412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome.
    McDermott NC; Milburn C; Curran B; Kay EW; Barry Walsh C; Leader MB
    J Pathol; 2000 Feb; 190(2):157-62. PubMed ID: 10657013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of nm23 expression to proliferation and prognosis in malignant melanomas of the oral cavity.
    Korabiowska M; Hönig JF; Jawien J; Knapik J; Stachura J; Cordon-Cardo C; Fischer G
    In Vivo; 2005; 19(6):1093-6. PubMed ID: 16277028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival.
    Döme B; Somlai B; Tímár J
    Anticancer Res; 2000; 20(5C):3971-4. PubMed ID: 11268486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
    Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
    Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.
    Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(1A):505-11. PubMed ID: 9066703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
    Seregard S; Oskarsson M; Spângberg B
    Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
    Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
    Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma.
    Thies A; Schachner M; Berger J; Moll I; Schulze HJ; Brunner G; Schumacher U
    J Pathol; 2004 Aug; 203(4):933-9. PubMed ID: 15258996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.
    Soliani P; Ziegler S; Romani A; Corcione L; Campanini N; Dell'Abate P; Del Rio P; Sianesi M
    Oncol Rep; 2004 Jun; 11(6):1193-200. PubMed ID: 15138555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of p53 oncoprotein expression in cutaneous melanoma.
    Ross DA; Wilson GD
    Br J Surg; 1997 Jun; 84(6):803-7. PubMed ID: 9189093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy.
    Pearl RA; Pacifico MD; Richman PI; Wilson GD; Grover R
    J Plast Reconstr Aesthet Surg; 2008; 61(3):265-71. PubMed ID: 17569608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
    Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA
    Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings.
    Tchernev G; Orfanos CE
    J Cutan Pathol; 2007 Mar; 34(3):247-56. PubMed ID: 17302609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
    Karbowniczek M; Chosia M; Domagała W
    Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic prediction of the immunohistochemical expression of p16 and p53 in cutaneous melanoma: a comparison of two populations from different geographical regions.
    Sirigu P; Piras F; Minerba L; Murtas D; Maxia C; Colombari R; Corbu A; Perra MT; Ugalde J
    Eur J Histochem; 2006; 50(3):191-8. PubMed ID: 16920642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein D expression in cutaneous malignant melanoma.
    Miranda E; Vizoso F; Martín A; Quintela I; Corte MD; Seguí ME; Ordiz I; Merino AM
    J Surg Oncol; 2003 Jun; 83(2):99-105. PubMed ID: 12772203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.